Biomarkers of histone deacetylase inhibitor activity in a phase 1 combined-modality study with radiotherapy.
about
Biomarkers of treatment toxicity in combined-modality cancer therapies with radiation and systemic drugs: study design, multiplex methods, molecular networksInduction of Apoptosis in Intestinal Toxicity to a Histone Deacetylase Inhibitor in a Phase I Study with Pelvic RadiotherapyPersonalized radiotherapy: concepts, biomarkers and trial designTreating Colon Cancer Cells with FK228 Reveals a Link between Histone Lysine Acetylation and Extensive Changes in the Cellular Proteome.
P2860
Biomarkers of histone deacetylase inhibitor activity in a phase 1 combined-modality study with radiotherapy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Biomarkers of histone deacetyl ...... ality study with radiotherapy.
@ast
Biomarkers of histone deacetyl ...... ality study with radiotherapy.
@en
type
label
Biomarkers of histone deacetyl ...... ality study with radiotherapy.
@ast
Biomarkers of histone deacetyl ...... ality study with radiotherapy.
@en
prefLabel
Biomarkers of histone deacetyl ...... ality study with radiotherapy.
@ast
Biomarkers of histone deacetyl ...... ality study with radiotherapy.
@en
P2093
P2860
P50
P1433
P1476
Biomarkers of histone deacetyl ...... ality study with radiotherapy.
@en
P2093
Erta Kalanxhi
Ingrid H G Østensen
Kristina Schee
Marie Grøn Saelen
Torveig Weum Abrahamsen
P2860
P304
P356
10.1371/JOURNAL.PONE.0089750
P407
P577
2014-02-25T00:00:00Z